title: Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.
abstract: Heparan sulfate (HS) binds and modulates the transport and activity of a large repertoire of regulatory proteins. The HS phage display antibodies are powerful tools for the analysis of native HS structure in situ; however, their epitopes are not well defined. Analysis of the binding specificities of a set of HS antibodies by competitive binding assays with well defined chemically modified heparins demonstrates that O-sulfates are essential for binding; however, increasing sulfation does not necessarily correlate with increased antibody reactivity. IC50 values for competition with double modified heparins were not predictable from IC50 values with corresponding singly modified heparins. Binding assays and immunohistochemistry revealed that individual antibodies recognize distinct epitopes and that these are not single linear sequences but families of structurally similar motifs in which subtle variations in sulfation and conformation modify the affinity of interaction. Modeling of the antibodies demonstrates that they possess highly basic CDR3 and surrounding surfaces, presenting a number of possible orientations for HS binding. Unexpectedly, there are significant differences between the existence of epitopes in tissue sections and observed in vitro in dot blotted tissue extracts, demonstrating that in vitro specificity does not necessarily correlate with specificity in situ/vivo. The epitopes are therefore more complex than previously considered. Overall, these data have significance for structure-activity relationships of HS, because the model of one antibody recognizing multiple HS structures and the influence of other in situ HS-binding proteins on epitope availability are likely to reflect the selectivity of many HS-protein interactions in vivo.
authors.affiliation: School of Biological Sciences, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
authors.forename: Sophie M
authors.initials: SM
authors.lastname: Thompson
authors.forename: David G
authors.initials: DG
authors.lastname: Fernig
authors.forename: Edwin C
authors.initials: EC
authors.lastname: Jesudason
authors.forename: Paul D
authors.initials: PD
authors.lastname: Losty
authors.forename: Els M A
authors.initials: EM
authors.lastname: van de Westerlo
authors.forename: Toin H
authors.initials: TH
authors.lastname: van Kuppevelt
authors.forename: Jeremy E
authors.initials: JE
authors.lastname: Turnbull
mesh_terms: D020816:Amino Acid Motifs / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000235:genetics / Q000276:immunology; D000915:Antibody Affinity; D000918:Antibody Specificity; D001666:Binding Sites, Antibody / Q000276:immunology; D000939:Epitopes / Q000737:chemistry* / Q000276:immunology; D006497:Heparan Sulfate / Q000737:chemistry* / Q000276:immunology; D051379:Mice; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D000911:Antibodies, Monoclonal; D000939:Epitopes; D006497:Heparan Sulfate